Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation of Tenofovir Disoproxil degradation impurity via selective hydrolysis. Enhancing API quality control and supply chain stability for global pharma.
Patent CN118652170A enables high-yield synthesis of Dapagliflozin intermediates with reduced waste and cost for global supply chains.
Patent CN103695495B details enzymatic resolution for Abacavir intermediates. Achieves high purity with reduced costs and reliable supply chain scalability.
Patent CN101891797A reveals a selective hydrolysis method for steroidal 17α-esters, offering superior yield and purity for pharmaceutical manufacturing supply chains.
Optimized low-temperature alkaline hydrolysis method for pemetrexed disodium intermediate ensuring high purity and industrial scalability for global supply chains.
Novel hydrolysis method enhances purity and yield for pemetrexed disodium intermediate manufacturing, offering significant supply chain reliability and cost reduction benefits for global pharmaceutical partners.
Patent CN1344712A details a robust telmisartan synthesis using methyl/ethyl esters, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN102241663B reveals a green aqueous synthesis for Strontium Ranelate. Achieve 90-95% yield with <0.3% impurities. Ideal for cost reduction in API manufacturing.
Advanced synthesis of Montelukast Sodium via CN111892535B. Achieves >99.8% purity and >93.5% yield without expensive ionic liquids, offering significant cost reduction.
Patent CN102417472A reveals high-yield Florfenicol synthesis. Enables cost reduction in veterinary drug manufacturing with scalable supply chain solutions.
Novel iodine-catalyzed synthesis for florfenicol. High purity, mild conditions. Reliable veterinary drugs supplier for commercial scale-up.
Patent CN112500311A reveals a novel benzophenone-mediated synthesis for O-3-chloro-2-propenyl hydroxylamine, offering >98% purity and recyclable reagents for clethodim production.
Novel alkaline hydrolysis method for Semaglutide backbone fragments. High purity, simplified steps, and cost-effective manufacturing for GLP-1 analog intermediates.
Patent CN111303047B reveals a high-yield synthesis of 2-amino-4,6-lutidine from 3-aminocrotonenitrile, offering superior purity and cost-effective manufacturing for global supply chains.
Novel ion-exchange purification method for Torasemide achieving >99.8% purity. Ideal for reliable torasemide suppliers seeking cost-effective scale-up.
Patent CN102311339A reveals a streamlined 2-step synthesis for Vitamin A key intermediate C5 aldehyde, offering significant cost reduction and simplified supply chain management for global manufacturers.
Discover the novel sulfuric acid hydrolysis route for DL-pantolactone in patent CN114773295A. Achieve high purity Vitamin B5 intermediates with reduced wastewater and solvent-free extraction.
Patent CN110981823B reveals high-purity triazole synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114085161B offers a cost-effective route for 5-ALA-HCl. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Novel patent CN105254611B enables waste-to-value synthesis. Reduces toxic waste and enhances supply chain reliability for pharmaceutical intermediates.